No products in the cart.
Antihypertensives reduce the rate of progressive aortic root dilation in Marfan syndrome
1. Compared to control, ARBs reduced the annual rate of increase of the aortic root Z score by approximately one-half. ...
Tag: angiotensin receptor blocker (ARB)
Effectiveness of sacubitril-valsartan in post-myocardial infarction management
1. In patients with acute myocardial infarction, Sacubitril-valsartan was not associated with a significantly lower incidence of death from cardiovascular ...
#VisualAbstract: Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
1. A 5 mmHg reduction in systolic blood pressure was linked to an 11% risk reduction of new-onset type 2 ...
#VisualAbstract: Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid19
1. Amongst the five examined classes of antihypertensive medications (ACE Inhibitors, ARBs, beta blockers, calcium-channel blockers, and thiazide diuretics), none ...
#VisualAbstract: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
1. Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) were not shown to affect the risk of coronavirus disease 2019 (Covid-19). ...
Risk of positive COVID-19 diagnosis not associated with ACE inhibitor or angiotensin receptor blocker use
1. No association was found between angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use and test-positivity for COVID-19. Evidence ...
2 Minute Medicine Rewind May 11, 2020
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19) ...
2 Minute Medicine Rewind May 4, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial 1. Adults with severe COVID-19 treated with remdesivir ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.